Team 3 QICD Cholesterol Screening in Diabetes Guidelines
-
Upload
halla-hobbs -
Category
Documents
-
view
20 -
download
0
description
Transcript of Team 3 QICD Cholesterol Screening in Diabetes Guidelines
Team 3 QICD Cholesterol Screening in Diabetes Guidelines
Diabetic Patient
LDL <100 (GOAL) LDL >100
Check FLP annuallyCheck FLP q6wksand titrate statin to
goal
1. ADA Standards of Medical Care 20102. ATP3 Guidelines 3. NCEP Guidelines4. Sathesivam S, Lecky B. Statin Induced Myopathy. BMJ 2008;337:a2286.5. Eckel R. Approach to the patient who is intolerant of statin therapy. J Clin Endocrinol Metab 2010; 95:2015-2022.
Frequently Asked Questions
1. What statin should I start with for someone who is newly diagnosed with hypercholesterolemia? Simvastatin
2. What is the starting dose of Simvastatin if someone is slightly above goal? 20 mg
3. What is the starting dose of Simvastatin if I would like at least a 45% decrease in LDL? 40 mg
4. Which statins are least associated with myopathy? Pravastatin, Rosuvastatin, and Fluvastatin
5. What statins are more potent than Simvastatin if someone is on the max dose of Simvastatin and still not at goal? Atorvastatin and Rosuvastatin
6. Why is controlling cholesterol so important? To prevent atherosclerosis!
Algorithm for Frequency of FLP measurement
Statin Approximate
Equivalent Dose
Percent Change from Baseline LDL
Initial dosing
Atorvastatin 10 mgLovastatin 40 mgPravastatin 40 mgSimvastatin 20 mg
-31 to -38% For a 30-40% reduction in LDL-C
Atorvastatin 20 mgLovastatin 80 mgRosuvastatin 5 mgSimvastatin 40 mg
-45 to -48% For a 45-50% reduction in LDL-C
Atorvastatin 40 mgRosuvastatin 10 mgSimvastatin 80 mg
-46 to -48% For a 50% reduction in LDL-C
Atorvastatin 80 mgRosuvastatin 20 mg
-51 to -52% For > 50% reduction in LDL-C (but will likely need to add
additional therapy)
Amy Egras, Pharm D